The fourth quarter of 2025 capped a period of important progress for PDS Biotech, marked by meaningful advances across our ...

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injectorSarclisa administered via ...

A federal appeals court says Alabama's use of nitrogen gas for executions needs more study to see if it violates the ...

Early trial data support quarterly dosing of an under-the-skin Briumvi formulation now being tested in Phase 3 for relapsing ...

Injections deliver liquid medications, fluids, or nutrients directly into a person’s body. Different types of injections include intravenous, intramuscular, subcutaneous, intraosseous, and intradermal ...

Skyrizi is a biologic medication used to treat several inflammatory conditions, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, and ulcerative colitis, in adults. Dosage typically ...

GIP infusion as add-on to placebo or semaglutide did not improve glycaemic control in individuals with type 2 diabetes at the prespecified target of 1·50 mmol/L. Due to dropouts, we cannot draw firm ...

Lumbar epidural steroid injections can ease lower back or leg pain from nerve inflammation. Doctors may recommend them when bed rest and pain relievers do not help. Pain relief often starts within 2 ...

Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in range Insulet-led sessions will ...

Wegovy is available as an injection and an oral tablet. Wegovy injection is approved by the FDA for weight management, cardiovascular risk reduction, and liver disease. The tablet is approved for ...

Tens of thousands of protesters joined two rival marches in London on Saturday - the Unite the Kingdom rally organised by far-right figure Tommy Robinson, and a pro-Palestinian demonstration. More ...

China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 ...